510(k) Report

510(k) · Cleared

Cleared

Immunocap Allergen Components Bundle

K113841510(k) TraditionalCleared Sep 13, 2012260-day reviewClass II21 CFR 866.5750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Phadia US, Inc. · DHB System, Test, Radioallergosorbent (Rast) Immunological

Cleared on Sep 13, 2012 as substantially equivalent to K051218 (Pharmacia Diagnostics AB, 2005) and 2 other predicates after a 260-day review. Its family tree reaches back 2 generations to 1990. 1 later device descends from it.

Decided
Sep 13, 2012
Review
260 days
Class
Class II
Product code
DHB
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K894190 (1990). 5 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor1996: 1 other ancestor1991: 1 other ancestor2016: 1 descendant clearedK894190 · Pharmacia Cap System Rast Ria & Rast Feia · Pharmacia, Inc. · 1990K991048 · Allergen Immunocap, Models E7, F93, F94, F95, F203, F204, F208, F209, F210, F214, F216, F235, F237, F242, F255, F259, F2 · Pharmacia & Upjohn Co. · 19991990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 1 other ancestor 1 generation forward: 1 descendant K991048 · Allergen Immunocap, Models E7, F93, F94, F95, F203, F204, F208, F209, F210, F214, F216, F235, F237, F242, F255, F259, F2 · Pharmacia & Upjohn Co. · 1999K894190 · Pharmacia Cap System Rast Ria & Rast Feia · Pharmacia, Inc. · 19900
  1. Root · 2 generations backK894190 Pharmacia Cap System Rast Ria & Rast FeiaPharmacia, Inc. · 1990
  2. 1 generation backK991048 Allergen Immunocap, Models E7, F93, F94, F95, F203, F204, F208…Pharmacia & Upjohn Co. · 1999
  3. This deviceK113841 Immunocap Allergen Components BundlePhadia US, Inc. · 2012
  4. Descendant · cites it directly · 0 of its ownK151029 Phadia PrimePhadia AB · 2016 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K151029Phadia PrimePhadia AB · 2016 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K894190Pharmacia Cap System Rast Ria & Rast FeiaPharmacia, Inc.1990—
−1K991048Allergen Immunocap, Models E7, F93, F94, F95, F203, F204, F208, F209, F210…Pharmacia & Upjohn Co.1999—
0 (this device)K113841Immunocap Allergen Components BundlePhadia US, Inc.2012—
+1K151029Phadia PrimePhadia AB20161

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199610
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
FIG. 1 — Lineage of K113841, 1990–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DHB device

  1. #1 K260331 IMMULITE 2000 3gAllergy Specific IgE Vantage…score 12.3 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051218Modification to: Unicap Specific IgePharmacia Diagnostics AB20053
*K962274Unicap 100
Summary page 2
…11 CFR 866.5750 Substantial Equivalence to: ImmunoCAP Specific IgE (kOS51218) UniCAP 100 (k962274) ImmunoCAP Allergen f95, Peach (k991048) Indications For Use Statement ImmunoCAP Specific IgE is an in vitro quantitati…
Pharmacia, Inc.1996—
*K991048Allergen Immunocap, Models E7, F93, F94, F95, F203, F204, F208, F209, F210, F214, F216…
Summary page 2
…5750 Substantial Equivalence to: ImmunoCAP Specific IgE (kOS51218) UniCAP 100 (k962274) ImmunoCAP Allergen f95, Peach (k991048) Indications For Use Statement ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specifi…
Pharmacia & Upjohn Co.1999—

Also cleared against K051218: 26 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K151029Phadia PrimePhadia AB20160

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 3 companies; a new generation was cleared every 13.3 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K151029 (Phadia AB, 2016) has gone furthest, with 0 descendants of its own.
  • 26 other devices also cite its predicate K051218.

How does its category compare?

All DHB devices

DHB System, Test, Radioallergosorbent (Rast) Immunological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · DHB

2in 2025

2007: 12008: 22009: 72010: 32011: 52012: 32013: 52014: 12015: 12016: 22017: 12018: 22019: 32020: 22021: 12022: 22025: 22026 (partial year): 6
2007high 7 (2009) · low 0 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHB

90in 2019

2009: 118 days median2010: 247 days median2011: 405 days median2012: 260 days median2013: 257 days median2019: 90 days median2026 (partial year): 138 days median
2007high 405 (2011) · low 90 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DHB

14in 2025

2012: 12014: 12017: 12018: 12022: 32025: 14
2007high 14 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHB

6in 2025

2008: 12011: 12012: 22015: 12017: 112018: 62019: 42021: 72022: 12023: 62024: 102025: 6
2007high 11 (2017) · low 0 (2007)2025

MAUDE reports naming product code DHB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—01
2009711800
2010324700
2011540501
2012326012
2013525700
20141—10
20151—01
20162—00
20171—111
20182—16
201939004
20202—00
20211—07
20222—31
20230—06
20240—010
20252—146
202661380—

What is it indicated for?

ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma (EDTA or Na-Heparin). ImmunoCAP Specific IgE is to be used with instruments Phadia 100, Phadia 250, and Phadia 1000. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of IgE mediated allergic disorders in conjunction with other clinical findings, and is to be used in clinical laboratories.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K113841: Immunocap Allergen Components Bundle.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K113841

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026